{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:03:24Z","timestamp":1780034604255,"version":"3.53.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-025-02220-7","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:15:15Z","timestamp":1771830915000},"page":"717-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of underlying kidney disease on the outcomes of cardiac implantable electronic devices in patients with heart failure"],"prefix":"10.1007","volume":"69","author":[{"given":"Amith","family":"Seri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rasheed","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Kambalapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Kidess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Hasan","family":"Jawadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7874-4566","authenticated-orcid":false,"given":"M. Chadi","family":"Alraies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"3","key":"2220_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036895","volume":"103","author":"C Elendu","year":"2024","unstructured":"Elendu C, Amaechi DC, Elendu TC, Fiemotonghan BE, Okoye OK, Agu-Ben CM, et al. A comprehensive review of heart failure: unraveling the etiology, decoding pathophysiological mechanisms, navigating diagnostic modalities, exploring pharmacological interventions, advocating lifestyle modifications, and charting the horizon of emerging therapies in the complex landscape of chronic cardiac dysfunction. Medicine (Baltimore). 2024;103(3):e36895.","journal-title":"Medicine (Baltimore)"},{"key":"2220_CR2","doi-asserted-by":"crossref","unstructured":"Bozkurt B, Ahmad T, Alexander K, Baker WL, Bosak K, Breathett K, et al. HF STATS 2024: heart failure epidemiology and outcomes Statistics an updated 2024 report from the Heart Failure Society of America. J Card Fail. 2024;","DOI":"10.1016\/j.cardfail.2024.07.001"},{"issue":"12","key":"2220_CR3","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/ejhf.821","volume":"19","author":"I L\u00f6fman","year":"2017","unstructured":"L\u00f6fman I, Szummer K, Dahlstr\u00f6m U, Jernberg T, Lund LH. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. Eur J Heart Fail. 2017;19(12):1606\u201314.","journal-title":"Eur J Heart Fail"},{"key":"2220_CR4","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.15420\/ecr.2021.54","volume":"17","author":"H Warrens","year":"2022","unstructured":"Warrens H, Banerjee D, Herzog CA. Cardiovascular complications of chronic kidney disease: an introduction. Eur Cardiol. 2022;17:e13.","journal-title":"Eur Cardiol"},{"issue":"24","key":"2220_CR5","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/eurheartj\/ehy060","volume":"39","author":"MP Turakhia","year":"2018","unstructured":"Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA, et al. Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Eur Heart J. 2018;39(24):2314\u201325.","journal-title":"Eur Heart J"},{"key":"2220_CR6","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.15420\/aer.2022.35","volume":"12","author":"A Naraen","year":"2023","unstructured":"Naraen A, Duvva D, Rao A. Heart failure and cardiac device therapy: a review of current National Institute of health and care excellence and European Society of Cardiology Guidelines. Arrhythm Electrophysiol Rev. 2023;12:e21.","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"7","key":"2220_CR7","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"M Tonelli","year":"2006","unstructured":"Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034\u201347.","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"2220_CR8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.jacc.2024.05.081","volume":"84","author":"CR Varga","year":"2024","unstructured":"Varga CR, Cleland JGF, Abraham WT, Lip GYH, Leyva F, Hatamizadeh P. Implantable cardioverter defibrillator and resynchronization therapy in patients with overt chronic kidney disease: JACC state-of-the-art review. J Am Coll Cardiol. 2024;84(14):1342\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"2220_CR9","unstructured":"Nationwide Inpatient Sample (NIS) HCaUPH. Agency for Healthcare Research and Quality; 2016-2021 Available from: https:\/\/hcup-us.ahrq.gov\/db\/nation\/nis\/nisdbdocumentation.jsp. Accessed Feb 2025."},{"key":"2220_CR10","unstructured":"NIS Documentation. Healthcare Cost and Utilization Project (HCUP). Available from: https:\/\/hcup-us.ahrq.gov\/db\/nation\/nis\/nisdbdocumentation.jsp. Accessed Feb 2025."},{"issue":"20","key":"2220_CR11","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1001\/jama.2017.17653","volume":"318","author":"R Khera","year":"2017","unstructured":"Khera R, Angraal S, Couch T, Welsh JW, Nallamothu BK, Girotra S, et al. Adherence to methodological standards in research using the National Inpatient Sample. JAMA. 2017;318(20):2011\u20138.","journal-title":"JAMA"},{"key":"2220_CR12","unstructured":"NIS data elements. US Agency for Healthcare Research and Quality. Available from: https:\/\/hcup-us.ahrq.gov\/db\/nation\/nis\/nisdde.jsp. Accessed Feb 2025."},{"key":"2220_CR13","unstructured":"HCUP Cost-to-Charge Ratio Files. US Agency for Healthcare Research and Quality. Available from: https:\/\/hcup-us.ahrq.gov\/db\/ccr\/costtocharge.jsp. Accessed Feb 2025."},{"key":"2220_CR14","unstructured":"Cunsumer Price Index for all urban Consumers (CPI-U). U.S. BUREAU OF LABOR STATISTICS. Available from: https:\/\/data.bls.gov\/cgi-bin\/surveymost?cu. Accessed Feb 2025."},{"issue":"4","key":"2220_CR15","first-page":"188","volume":"12","author":"WP Glasheen","year":"2019","unstructured":"Glasheen WP, Cordier T, Gumpina R, Haugh G, Davis J, Renda A. Charlson comorbidity index: ICD-9 update and ICD-10 translation. Am Health Drug Benefits. 2019;12(4):188\u201397.","journal-title":"Am Health Drug Benefits"},{"key":"2220_CR16","unstructured":"HCUP National Estimates Course. Agency for Healthcare Research and Quality (AHRQ). 2018. Available from: https:\/\/hcup-us.ahrq.gov\/tech_assist\/nationalestimates\/508_course\/508course_2018.jsp. Accessed Feb 2025."},{"issue":"1","key":"2220_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12874-020-00948-6","volume":"20","author":"BE Bailey","year":"2020","unstructured":"Bailey BE, Andridge R, Shoben AB. Multiple imputation by predictive mean matching in cluster-randomized trials. BMC Med Res Methodol. 2020;20(1):72.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"2220_CR18","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1177\/09622802231198795","volume":"32","author":"PC Austin","year":"2023","unstructured":"Austin PC, van Buuren S. Logistic regression vs. predictive mean matching for imputing binary covariates. Stat Methods Med Res. 2023;32(11):2172\u201383.","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"2220_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150\u201361.","journal-title":"Pharm Stat"},{"issue":"4","key":"2220_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101548","volume":"48","author":"KM Talha","year":"2023","unstructured":"Talha KM, Jain V, Yamani N, Fatima K, Rashid AM, Hernandez GA, et al. Temporal trends and outcomes of implantable cardioverter defibrillators in heart failure and chronic kidney disease in the United States. Curr Probl Cardiol. 2023;48(4):101548.","journal-title":"Curr Probl Cardiol"},{"key":"2220_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amjcard.2022.11.011","volume":"188","author":"M Al-Sadawi","year":"2023","unstructured":"Al-Sadawi M, Aslam F, Tao M, Ijaz H, Alsaiqali M, Fan R, et al. Effect of implanted defibrillator on mortality in patients with chronic kidney disease. Am J Cardiol. 2023;188:36\u201340.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2220_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10840-018-0424-1","volume":"53","author":"M Shurrab","year":"2018","unstructured":"Shurrab M, Ko DT, Zayed Y, Navaneethan SD, Yadak N, Yaseen A, et al. Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients. J Interv Card Electrophysiol. 2018;53(1):123\u20139.","journal-title":"J Interv Card Electrophysiol"},{"issue":"2","key":"2220_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10840-010-9484-6","volume":"28","author":"F Khan","year":"2010","unstructured":"Khan F, Adelstein E, Saba S. Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patients. J Interv Card Electrophysiol. 2010;28(2):117\u201323.","journal-title":"J Interv Card Electrophysiol"},{"issue":"1","key":"2220_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.ajkd.2013.12.009","volume":"64","author":"PH Pun","year":"2014","unstructured":"Pun PH, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, et al. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis. 2014;64(1):32\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"2220_CR25","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.2215\/CJN.00620115","volume":"10","author":"U H\u00f6ke","year":"2015","unstructured":"H\u00f6ke U, Khidir MJ, van der Velde ET, Schalij MJ, Bax JJ, Delgado V, et al. Cardiac resynchronization therapy in CKD stage 4 patients. Clin J Am Soc Nephrol. 2015;10(10):1740\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"2220_CR26","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/pace.12685","volume":"38","author":"G Singal","year":"2015","unstructured":"Singal G, Upadhyay GA, Borgquist R, Friedman DJ, Chatterjee NA, Kandala J, et al. Renal response in patients with chronic kidney disease predicts outcome following cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2015;38(10):1192\u2013200.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"10","key":"2220_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cardfail.2019.07.005","volume":"25","author":"JM Ter Maaten","year":"2019","unstructured":"Ter Maaten JM, Martens P, L\u2019Hoyes W, Maass AH, Damman K, Dupont M, et al. Response to cardiac resynchronization therapy across chronic kidney disease stages. J Card Fail. 2019;25(10):803\u201311.","journal-title":"J Card Fail"},{"issue":"1","key":"2220_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1186\/s12879-023-08773-0","volume":"23","author":"PJ Wu","year":"2023","unstructured":"Wu PJ, Chen HC, Fang YN, Chong SZ, Chen YL, Chen MC. Device-related infection and mortality in patients with chronic kidney disease receiving cardiac implantable electronic devices: a propensity score-matched cohort study. BMC Infect Dis. 2023;23(1):787.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2220_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1540-8159.2007.00677.x","volume":"30","author":"C Chen-Scarabelli","year":"2007","unstructured":"Chen-Scarabelli C, Scarabelli TM. Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol. 2007;30(3):371\u20136.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"2","key":"2220_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1540-8159.2007.00651.x","volume":"30","author":"PS Cuculich","year":"2007","unstructured":"Cuculich PS, S\u00e1nchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, et al. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol. 2007;30(2):207\u201313.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"2220_CR31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jamainternmed.2017.8462","volume":"178","author":"N Bansal","year":"2018","unstructured":"Bansal N, Szpiro A, Reynolds K, Smith DH, Magid DJ, Gurwitz JH, et al. Long-term outcomes associated with implantable cardioverter defibrillator in adults with chronic kidney disease. JAMA Intern Med. 2018;178(3):390\u20138.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2220_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1540-8159.2006.00307.x","volume":"29","author":"H Bloom","year":"2006","unstructured":"Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol. 2006;29(2):142\u20135.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"2220_CR33","doi-asserted-by":"publisher","first-page":"e2587","DOI":"10.1097\/MD.0000000000002587","volume":"95","author":"YS Lin","year":"2016","unstructured":"Lin YS, Chen TH, Lin MS, Chen DY, Mao CT, Hsu JT, et al. Impact of chronic kidney disease on short-term cardiac implantable electronic device related infection: a Nationwide population-based cohort study. Medicine (Baltimore). 2016;95(5):e2587.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2220_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/europace\/euv053","volume":"17","author":"KA Polyzos","year":"2015","unstructured":"Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17(5):767\u201377.","journal-title":"Europace"},{"issue":"11","key":"2220_CR35","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJM199003153221102","volume":"322","author":"P Ruiz","year":"1990","unstructured":"Ruiz P, Gomez F, Schreiber AD. Impaired function of macrophage fc gamma receptors in end-stage renal disease. N Engl J Med. 1990;322(11):717\u201322.","journal-title":"N Engl J Med"},{"issue":"10","key":"2220_CR36","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1540-8167.2011.02066.x","volume":"22","author":"C Tompkins","year":"2011","unstructured":"Tompkins C, McLean R, Cheng A, Brinker JA, Marine JE, Nazarian S, et al. End-stage renal disease predicts complications in pacemaker and ICD implants. J Cardiovasc Electrophysiol. 2011;22(10):1099\u2013104.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"2220_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1053\/j.ajkd.2011.03.026","volume":"58","author":"DM Charytan","year":"2011","unstructured":"Charytan DM, Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA, et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011;58(3):409\u201317.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"2220_CR38","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1093\/ndt\/14.12.2807","volume":"14","author":"M Girndt","year":"1999","unstructured":"Girndt M, Sester U, Sester M, Kaul H, K\u00f6hler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant. 1999;14(12):2807\u201310.","journal-title":"Nephrol Dial Transplant"},{"key":"2220_CR39","doi-asserted-by":"crossref","unstructured":"Guha A, Maddox WR, Colombo R, Nahman NS Jr, Kintziger KW, Waller JL, et al. Cardiac implantable electronic device infection in patients with end-stage renal disease. Heart Rhythm. 2015;12(12):2395\u2013401.","DOI":"10.1016\/j.hrthm.2015.08.003"},{"key":"2220_CR40","doi-asserted-by":"crossref","unstructured":"Calvert MJ, Freemantle N, Yao G, Cleland JG, Billingham L, Daubert JC, et al. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J. 2005;26(24):2681\u20138.","DOI":"10.1093\/eurheartj\/ehi662"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-02220-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-025-02220-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-02220-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:39:50Z","timestamp":1780033190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-025-02220-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2220"],"URL":"https:\/\/doi.org\/10.1007\/s10840-025-02220-7","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No author of this study has any kind of competing of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}